A new study suggests that babies are able to distinguish between the different objects they see around them at 2 months old, ...
The manufacturer's warranty isn't the be-all, end-all.
Jabalpur: Eighteen members of a Patel family from Narsinghpur district were hospitalised after allegedly consuming ...
Eat a diet full of fruits, vegetables, whole grains, and lean proteins for better survival rates. Include immune-boosting foods like bell peppers, citrus fruits, and garlic. Get enough calcium and ...
The woman said her husband is “threatening divorce” because she’s going to a work event Latoya Gayle joined PEOPLE as an Associate Editor in 2024. Her work has previously appeared in The U.S. Sun, ...
The FDA has granted accelerated approval to sevabertinib (Hyrnuo, Bayer Healthcare Pharmaceuticals Inc) for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors ...
From electronic health records and blood tests to the stream of data from wearable devices, the amount of health information people generate is accelerating rapidly. Yet, many users struggle to ...
Sevabertinib received accelerated FDA approval for HER2 TKD-mutant nonsquamous NSCLC, showing a 71% ORR in the SOHO-01 trial. The treatment demonstrated a tolerable safety profile, with diarrhea as ...
Three years after striking up a Zymeworks licensing pact with an eye on challenging the status quo in HER2-positive cancers, Jazz Pharmaceuticals is seeing its vision with Ziihera come into clearer ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Trastuzumab deruxtecan has shown efficacy in patients with previously treated human epidermal growth factor receptor 2 (HER2)–positive advanced or metastatic breast cancer. The efficacy and safety of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results